Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 48 | 2024 | 2427 | 7.280 |
Why?
|
Breast Neoplasms | 66 | 2024 | 21025 | 4.590 |
Why?
|
Ultrasonography, Mammary | 14 | 2023 | 239 | 3.760 |
Why?
|
Breast | 19 | 2024 | 1963 | 2.920 |
Why?
|
Calcinosis | 7 | 2023 | 1476 | 1.590 |
Why?
|
Burnout, Professional | 5 | 2022 | 702 | 1.390 |
Why?
|
Breast Diseases | 5 | 2016 | 443 | 1.270 |
Why?
|
Early Detection of Cancer | 16 | 2023 | 3202 | 1.260 |
Why?
|
Radiographic Image Enhancement | 10 | 2023 | 875 | 1.230 |
Why?
|
Magnetic Resonance Imaging | 20 | 2023 | 36290 | 1.110 |
Why?
|
Continuity of Patient Care | 3 | 2019 | 1066 | 1.090 |
Why?
|
Image Enhancement | 5 | 2016 | 2881 | 1.040 |
Why?
|
Radiology | 6 | 2022 | 2102 | 0.780 |
Why?
|
Retrospective Studies | 52 | 2024 | 80372 | 0.770 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2017 | 1215 | 0.640 |
Why?
|
Biopsy, Needle | 5 | 2022 | 1630 | 0.640 |
Why?
|
Mass Screening | 11 | 2022 | 5423 | 0.620 |
Why?
|
Mammary Glands, Human | 1 | 2019 | 203 | 0.590 |
Why?
|
Female | 69 | 2024 | 391270 | 0.530 |
Why?
|
Academic Medical Centers | 6 | 2023 | 2754 | 0.530 |
Why?
|
Diagnostic Errors | 2 | 2014 | 1266 | 0.510 |
Why?
|
Precancerous Conditions | 2 | 2019 | 977 | 0.510 |
Why?
|
Thoracic Diseases | 2 | 2016 | 99 | 0.490 |
Why?
|
Sensitivity and Specificity | 12 | 2023 | 14660 | 0.470 |
Why?
|
Carcinoma, Lobular | 4 | 2021 | 489 | 0.470 |
Why?
|
Hospital Information Systems | 1 | 2016 | 394 | 0.470 |
Why?
|
Humans | 94 | 2024 | 760621 | 0.470 |
Why?
|
Lymphatic Diseases | 1 | 2016 | 319 | 0.460 |
Why?
|
Soft Tissue Infections | 1 | 2016 | 168 | 0.450 |
Why?
|
Quality Improvement | 3 | 2021 | 3836 | 0.450 |
Why?
|
Axilla | 3 | 2023 | 626 | 0.440 |
Why?
|
Aftercare | 1 | 2019 | 916 | 0.420 |
Why?
|
Resilience, Psychological | 1 | 2020 | 768 | 0.420 |
Why?
|
Biopsy | 9 | 2022 | 6771 | 0.410 |
Why?
|
Carcinoma | 3 | 2019 | 2331 | 0.410 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1502 | 0.380 |
Why?
|
Diagnosis, Differential | 13 | 2020 | 12965 | 0.380 |
Why?
|
Contrast Media | 5 | 2019 | 5305 | 0.360 |
Why?
|
Abscess | 1 | 2014 | 605 | 0.360 |
Why?
|
Neoadjuvant Therapy | 2 | 2023 | 2821 | 0.350 |
Why?
|
Ultrasonography, Doppler | 2 | 2002 | 465 | 0.340 |
Why?
|
Middle Aged | 37 | 2024 | 220352 | 0.330 |
Why?
|
Aged | 33 | 2024 | 169152 | 0.330 |
Why?
|
Adult | 37 | 2024 | 219994 | 0.330 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2023 | 733 | 0.290 |
Why?
|
Vascular Diseases | 1 | 2016 | 1182 | 0.280 |
Why?
|
Neoplasms | 4 | 2023 | 22072 | 0.280 |
Why?
|
Artifacts | 3 | 2023 | 1898 | 0.270 |
Why?
|
Job Satisfaction | 2 | 2020 | 539 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9276 | 0.270 |
Why?
|
Inflammatory Breast Neoplasms | 2 | 2021 | 146 | 0.270 |
Why?
|
Mastectomy, Segmental | 3 | 2000 | 972 | 0.260 |
Why?
|
Aged, 80 and over | 16 | 2020 | 58995 | 0.260 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2363 | 0.260 |
Why?
|
Reproducibility of Results | 7 | 2020 | 20080 | 0.250 |
Why?
|
Self Report | 3 | 2021 | 3711 | 0.240 |
Why?
|
Gadolinium DTPA | 2 | 2019 | 823 | 0.240 |
Why?
|
Observer Variation | 4 | 2018 | 2601 | 0.210 |
Why?
|
Electronics | 2 | 2021 | 315 | 0.210 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2018 | 1096 | 0.210 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3696 | 0.190 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2017 | 936 | 0.180 |
Why?
|
Lymph Nodes | 2 | 2023 | 3486 | 0.180 |
Why?
|
Thrombophlebitis | 1 | 2001 | 288 | 0.180 |
Why?
|
Faculty | 2 | 2021 | 383 | 0.180 |
Why?
|
Mastectomy | 3 | 2023 | 1832 | 0.180 |
Why?
|
Referral and Consultation | 3 | 2023 | 3598 | 0.170 |
Why?
|
Arm | 1 | 2002 | 583 | 0.170 |
Why?
|
Predictive Value of Tests | 5 | 2023 | 15289 | 0.170 |
Why?
|
Subcutaneous Fat | 1 | 2023 | 393 | 0.170 |
Why?
|
Physicians | 3 | 2022 | 4591 | 0.170 |
Why?
|
Neoplasms, Second Primary | 3 | 2018 | 1056 | 0.150 |
Why?
|
Computer Systems | 1 | 2000 | 470 | 0.150 |
Why?
|
Catheterization, Central Venous | 1 | 2002 | 526 | 0.150 |
Why?
|
Internship and Residency | 1 | 2018 | 5870 | 0.150 |
Why?
|
Reimbursement, Incentive | 1 | 2022 | 542 | 0.140 |
Why?
|
Nipples | 1 | 1998 | 221 | 0.130 |
Why?
|
Abdominal Neoplasms | 1 | 1998 | 286 | 0.130 |
Why?
|
Neoplasm Invasiveness | 4 | 2018 | 3618 | 0.130 |
Why?
|
Lymphatic Metastasis | 2 | 2023 | 2943 | 0.130 |
Why?
|
Pelvic Neoplasms | 1 | 1998 | 248 | 0.130 |
Why?
|
Workload | 2 | 2020 | 847 | 0.130 |
Why?
|
Fibroma | 1 | 2017 | 190 | 0.130 |
Why?
|
False Negative Reactions | 1 | 2017 | 573 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2021 | 696 | 0.130 |
Why?
|
Body Piercing | 1 | 2014 | 9 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 707 | 0.120 |
Why?
|
Cattle | 1 | 2020 | 3847 | 0.120 |
Why?
|
Algorithms | 3 | 2023 | 13981 | 0.110 |
Why?
|
Models, Animal | 1 | 2020 | 2117 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 8950 | 0.110 |
Why?
|
User-Computer Interface | 1 | 2000 | 1403 | 0.110 |
Why?
|
Venous Thrombosis | 1 | 2002 | 1299 | 0.110 |
Why?
|
Suction | 1 | 2014 | 263 | 0.110 |
Why?
|
Breast Implants | 1 | 2017 | 410 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2016 | 3340 | 0.110 |
Why?
|
Pressure | 1 | 2016 | 1156 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2256 | 0.100 |
Why?
|
Ultrasonography | 5 | 2020 | 5961 | 0.100 |
Why?
|
Young Adult | 6 | 2017 | 58741 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39261 | 0.100 |
Why?
|
Skin Neoplasms | 1 | 2011 | 5799 | 0.100 |
Why?
|
Testicular Diseases | 2 | 2003 | 73 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1928 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2022 | 5201 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2023 | 3301 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2362 | 0.090 |
Why?
|
Premenopause | 1 | 2013 | 1038 | 0.080 |
Why?
|
Risk Factors | 6 | 2017 | 74359 | 0.080 |
Why?
|
Drainage | 1 | 2014 | 1161 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2000 | 1913 | 0.080 |
Why?
|
Internet | 1 | 2000 | 3078 | 0.070 |
Why?
|
Postpartum Period | 1 | 2014 | 1167 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11152 | 0.070 |
Why?
|
Breast Feeding | 1 | 2014 | 1355 | 0.060 |
Why?
|
Testicular Neoplasms | 2 | 2003 | 801 | 0.060 |
Why?
|
Weight Loss | 1 | 2016 | 2686 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8624 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4775 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9280 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4319 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4283 | 0.060 |
Why?
|
Adolescent | 5 | 2017 | 87810 | 0.060 |
Why?
|
Massachusetts | 1 | 2016 | 8803 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2688 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3986 | 0.060 |
Why?
|
Comorbidity | 2 | 2017 | 10551 | 0.060 |
Why?
|
Medicare | 1 | 2021 | 6786 | 0.050 |
Why?
|
Calculi | 1 | 2003 | 49 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14495 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3527 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4783 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3925 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8469 | 0.050 |
Why?
|
Patient Care Team | 1 | 2013 | 2511 | 0.050 |
Why?
|
Lithiasis | 1 | 2001 | 19 | 0.050 |
Why?
|
United States | 2 | 2021 | 72461 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4897 | 0.050 |
Why?
|
Germinoma | 1 | 2001 | 132 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20509 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15687 | 0.040 |
Why?
|
Teleradiology | 1 | 1999 | 53 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 1998 | 6853 | 0.040 |
Why?
|
Vena Cava Filters | 1 | 2001 | 261 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2000 | 15697 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 852 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1155 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2021 | 442 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 9073 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 3465 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15840 | 0.030 |
Why?
|
Keratins | 1 | 2017 | 497 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2018 | 424 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5889 | 0.030 |
Why?
|
Polyps | 1 | 1997 | 197 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 698 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3529 | 0.030 |
Why?
|
Incidence | 1 | 2012 | 21392 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2000 | 908 | 0.030 |
Why?
|
Endometrium | 1 | 1997 | 403 | 0.030 |
Why?
|
Internal Medicine | 1 | 2021 | 1048 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6377 | 0.030 |
Why?
|
Pregnancy | 2 | 2014 | 29749 | 0.030 |
Why?
|
Video Recording | 1 | 2018 | 955 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2932 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 1995 | 549 | 0.030 |
Why?
|
Tamoxifen | 1 | 1997 | 963 | 0.030 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1994 | 255 | 0.020 |
Why?
|
Radiography | 1 | 2022 | 6965 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 41335 | 0.020 |
Why?
|
Spleen | 1 | 1997 | 2298 | 0.020 |
Why?
|
Radiology Information Systems | 1 | 1996 | 528 | 0.020 |
Why?
|
Fatty Liver | 1 | 1997 | 778 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3448 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 1995 | 796 | 0.020 |
Why?
|
Software | 2 | 2000 | 4419 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 1996 | 1014 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 1997 | 1529 | 0.020 |
Why?
|
Animals | 1 | 2020 | 167963 | 0.020 |
Why?
|
Logistic Models | 1 | 2002 | 13314 | 0.020 |
Why?
|
Male | 6 | 2016 | 359744 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17165 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29658 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 2001 | 2543 | 0.020 |
Why?
|
Endometrial Neoplasms | 1 | 1997 | 1357 | 0.020 |
Why?
|
Risk Assessment | 2 | 2018 | 24123 | 0.020 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1994 | 1375 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54303 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9185 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9716 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11071 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1997 | 4925 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11712 | 0.010 |
Why?
|
Liver | 1 | 1997 | 7509 | 0.010 |
Why?
|
Time Factors | 2 | 2000 | 40165 | 0.010 |
Why?
|
Orchiectomy | 1 | 2001 | 470 | 0.010 |
Why?
|
Testis | 1 | 2001 | 794 | 0.010 |
Why?
|
Therapy, Computer-Assisted | 1 | 1999 | 267 | 0.010 |
Why?
|
X-Ray Intensifying Screens | 1 | 1996 | 32 | 0.010 |
Why?
|
Computer Terminals | 1 | 1996 | 41 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2475 | 0.010 |
Why?
|
Breast Neoplasms, Male | 1 | 1997 | 221 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1385 | 0.010 |
Why?
|
Reference Standards | 1 | 1997 | 1004 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 1996 | 532 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1997 | 1791 | 0.010 |
Why?
|
Research | 1 | 1999 | 1974 | 0.010 |
Why?
|
Lymphoma, Follicular | 1 | 1994 | 453 | 0.010 |
Why?
|
Intensive Care Units, Neonatal | 1 | 1996 | 833 | 0.000 |
Why?
|
Radiography, Interventional | 1 | 1995 | 1114 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1996 | 26181 | 0.000 |
Why?
|
Child | 1 | 1996 | 79806 | 0.000 |
Why?
|
Concepts
(214)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(60)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_